Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ONCR

Oncorus (ONCR)

Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONCR
DateTimeSourceHeadlineSymbolCompany
08/07/20236:52AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCROncorus Inc
08/03/20235:00PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ONCROncorus Inc
08/03/20234:38PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCROncorus Inc
08/03/20234:36PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCROncorus Inc
07/28/20234:40PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCROncorus Inc
07/28/20234:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCROncorus Inc
06/26/20234:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
06/23/20236:31AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONCROncorus Inc
06/16/20239:21AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONCROncorus Inc
06/12/20236:45AMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ONCROncorus Inc
06/09/20234:27PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
06/01/20234:35PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
06/01/20234:05PMGlobeNewswire Inc.Oncorus Announces Workforce Reduction PlanNASDAQ:ONCROncorus Inc
05/22/20235:01PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONCROncorus Inc
05/22/20234:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
05/22/20234:05PMGlobeNewswire Inc.Oncorus Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
05/18/20234:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
05/16/20234:38PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ONCROncorus Inc
05/05/20235:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
05/01/20237:36AMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ONCROncorus Inc
05/01/20236:40AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
03/24/20234:08PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ONCROncorus Inc
03/24/20237:28AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
03/24/20237:00AMGlobeNewswire Inc.Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
03/14/20234:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
02/14/20238:05AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
02/13/202312:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
02/02/20232:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
01/04/20237:00AMGlobeNewswire Inc.Oncorus Announces Research Collaboration with Daewoong Pharmaceutical for the Development of Lipid Nanoparticle Formulations for mRNA Drug CandidatesNASDAQ:ONCROncorus Inc
12/27/20226:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
 Showing the most relevant articles for your search:NASDAQ:ONCR